1
Tan-Sindhunata, M.B., Matthijssen, I.B., Smit, M., Baas, F., de Vries, J.I.P., van der Voorn, J.P., Kluijt, I., Hagen, M.A., Blom, E.W., Sistermans, E.A., Heijboer-Meijers, J.E., Waisfisz, Q., Weiss, M.M., Groffen, A.J.A.
Veröffentlicht in: Tan-Sindhunata , M B , Matthijssen , I B , Smit , M , Baas , F , de Vries , J I P , van der Voorn , J P , Kluijt , I , Hagen , M A , Blom , E W , Sistermans , E A , Heijboer-Meijers , J E , Waisfisz , Q , Weiss , M M & Groffen , A J A 2015 , ' Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence. ' , European Journal of Human Genetics , vol. 23 , no. 9 , pp. 1151-1157 . https://doi.org/10.1038/ejhg.2014.273;
2015
Veröffentlicht in: Tan-Sindhunata , M B , Matthijssen , I B , Smit , M , Baas , F , de Vries , J I P , van der Voorn , J P , Kluijt , I , Hagen , M A , Blom , E W , Sistermans , E A , Heijboer-Meijers , J E , Waisfisz , Q , Weiss , M M & Groffen , A J A 2015 , ' Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence. ' , European Journal of Human Genetics , vol. 23 , no. 9 , pp. 1151-1157 . https://doi.org/10.1038/ejhg.2014.273;
2015
2
van Oort, S., Rutters, F., Warlé-van Herwaarden, M. F., Schram, M. T., Stehouwer, C. D., Tack, C. J., Abbink, E. J., Wolffenbuttel, B. H., van der Klauw, M. M., DeVries, J. H., Siegelaar, S. E., Sijbrands, E. J., Özcan, B., de Valk, H. W., Silvius, B., Schroijen, M. A., Jazet, I. M., van Ballegooijen, A. J., Beulens, J. W.J., Elders, P. J., Kramers, C.
Veröffentlicht in: van Oort , S , Rutters , F , the Diabetes Pearl from the Parelsnoer Initiative , Warlé-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Özcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , e14406 . https://doi.org/10.1111/dme.14406;
2021
Veröffentlicht in: van Oort , S , Rutters , F , the Diabetes Pearl from the Parelsnoer Initiative , Warlé-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Özcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , e14406 . https://doi.org/10.1111/dme.14406;
2021